Recently, a review on polycythemia vera (PV) was published in Current Medical Research and Opinion discussing blood counts, treatments, and clinical outcomes of more than 5,800 patients with PV. Learn more.? https://bit.ly/4kKRL8L
关于我们
The Incyte Medical showcase page shares scientific information about Incyte's product portfolio, molecular targets and disease states under investigation, as well as emerging clinical data. Our unique expertise in medicinal chemistry and biology has enabled us to create a diversified portfolio of marketed products and clinical candidates, the majority of which were discovered by Incyte scientists. We are advancing a growing pipeline of medicines across Oncology and Inflammation & Autoimmunity. See our Community Guidelines: bit.ly/2sV0H5W Content is intended for US healthcare professionals.
- 网站
-
https://www.incytemi.com/
Incyte Medical的外部链接
- 所属行业
- 制药业
- 规模
- 1,001-5,000 人
动态
-
People living with myeloproliferative neoplasms (MPNs) experience emotional and social impacts resulting from their disease, including impacts on their ability to work. A new report, developed in collaboration with patients, patient advocates, and healthcare providers outlines key challenges and recommendations to help improve patient support and outcomes.?https://bit.ly/4ibpDtI
Explore the MPN Consensus Report
-
We’ve announced results from Phase 3 studies of an investigational oral JAK1 inhibitor in adults with moderate to severe hidradenitis suppurativa (HS). Learn more. https://bit.ly/4kWuOzf
-
At Incyte, we are dedicated to investigating potential treatments for patients with chronic graft-versus-host disease (GVHD). Visit our website to learn about the latest Phase 2 clinical trial for patients with this complex immune-mediated condition.?https://bit.ly/4iLDgzO
Discover Clinical Trials for Chronic GVHD
-
We are dedicated to empowering medical professionals by offering educational materials and resources on our website. Visit IncyteMI.com to learn more!
Visit our Medical Information Website
-
Thank you to the American Academy of Dermatology (AAD) for another excellent meeting. Learn more about the data presented at #AAD2025 by visiting our website. https://bit.ly/3DDxSj6
AAD 2025 Recap
-
In 2021, there were more than 81,000 people in the US living with squamous cell carcinoma of the anal canal (SCAC), the most common type of anal cancer. This #AnalCancerAwarenessMonth, learn more about SCAC and its risk factors.?https://bit.ly/3FdG7D5
Anal Cancer Awareness Month
-
Learn more about a sub-group analysis from the Phase 3 study of a topical JAK1/JAK2 inhibitor in pediatric patients (ages 2 to 11) with moderate to more extensive atopic dermatitis (AD) we presented at the American Academy of Dermatology Annual Meeting. #AAD2025?https://bit.ly/43sDc39
AD Data Presented at AAD 2025
-
At the Global Vitiligo Foundation (GVF) Annual Scientific Symposium, we presented new data in patients with vitiligo, including real-world insights. Visit our website to learn more. #GVF2025?https://bit.ly/4kvkRbW
Understand the Vitiligo Patient Experience
-
Join us at the upcoming American Academy of Dermatology (AAD) Annual Meeting to explore the latest advancements in our dermatology portfolio. Learn more. #AAD2025 https://bit.ly/41JiVoN
Incyte Oral Presentations and ePosters at AAD 2025